Impact Factor
4.05
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.41
1,305 total citations
h5-index
42
h5 depth signal
Cited share
88.8%
231 of 260
Total citations
1,305
Citation footprint
Metric signal
4.73
External metric anchor
Self-citation
2.5%
33 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
823
China
200
Canada
173
Denmark
97
Australia
86
Citing Fields of Research
Diabetes
932
Physiology
275
Endocrinology & Metabolism
191
Musculoskeletal Disorders
144
Sports Science
139
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
12,212
Articles tracked across the journal lifetime
Indexed publication set
260
231 cited publications
Last 12 months
165
13.8 publications/month
Open access share
15.8%
26 OA publications in the last year
Leading citing country
United States
823 citing publications
Leading citing field
Diabetes
932 citing publications
Latest tracked publication
1 October 2026
10 recent records available
Coverage & Indexing History
v278n1, Jan. 2000-
v278n1, Jan. 2000-
Active Coverage
Research Focus & Classification
Indexed Subjects
Diabetes
Issuing & Sponsoring Bodies
Contributor
American Physiological Society (1887- )
Broad Categories
Endocrinology
Metabolism
Physiology
Diabetes
MeSH Descriptors
Endocrine System Diseases
Endocrinology
Metabolic Diseases
Metabolism
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1152/ajpendo.00037.2025_cor
Open DOI
Correction for Ghias et al., volume 329, 2025, p. E143–E150
02
DOI 10.1152/ajpendo.00022.2026_cor
Open DOI
Correction for Jameson et al., volume 330, 2026, p. E782–E795
03
DOI 10.1152/ajpendo.00192.2026
Open DOI
Females with normal-weight obesity display evidence of postprandial dyslipidemia and basal intestinal permeability
We present new evidence that females with normal-weight obesity are characterized by postprandial dyslipidemia and basal intestinal permeability, which may be implicated in their documented cardiometabolic disease risk.
04
DOI 10.1152/ajpendo.00163.2026
Open DOI
Glucose-lowering in type 2 diabetes may be mediated by improved proinsulin processing without better β-cell compensation
In this report, mediation analyses identify the fasting proinsulin-to-C-peptide ratio as a biologic determinant of the A1c treatment effect observed in a recently reported clinical trial in which the study interventions had no differenti...
05
DOI 10.1152/ajpendo.00077.2026
Open DOI
Additive effects of metformin on glucose homeostasis after metabolic-bariatric surgery in nonobese insulin-deficient diabetic rats
Metabolic-bariatric surgery and metformin each improved glucose regulation in nonobese, insulin-deficient female GK rats. Their combination further reduced postprandial glycemic excursions without additional effects on insulin sensitivit...
06
DOI 10.1152/ajpendo.00108.2026
Open DOI
Enhanced behavioral responses to ghrelin administration are unaffected by ghrelin deficiency in a DHT-induced PCOS mouse model
This study uniquely examined how ghrelin deficiency interacts with prepubertal chronic DHT exposure, a PMOS mouse model, shaping metabolism and eating behavior in female mice. Although ghrelin deficiency minimally altered DHT-induced rep...
07
DOI 10.1152/ajpendo.00083.2026
Open DOI
Adipocyte β3-adrenergic receptor signaling attenuates leptin production but is dispensable for fasting induced leptin suppression
This study introduces a novel Adrb3 transcriptional block mouse model that enables global inactivation or adipocyte-specific reexpression of β3-adrenergic receptor signaling. Using this approach, we demonstrate that adipocyte β3-adrenerg...
08
DOI 10.1152/ajpendo.00105.2026
Open DOI
Mechanistic drivers of thermogenic adipose tissue dysfunction in aging and obesity
Population aging is accelerating worldwide and is accompanied by a growing burden of chronic metabolic diseases. Adipose tissue dysfunction represents a central mechanism linking aging and obesity to metabolic decline, contributing to ch...
09
DOI 10.1152/ajpendo.00113.2026
Open DOI
A noninvasive 13 C-mannitol breath test to monitor semaglutide treatment-induced delayed oral-cecal transit in mice
A novel noninvasive assay uses orally administered 13 C-mannitol, metabolized by cecal microbiota into exhaled 13 CO 2 , to enable continuous, longitudinal measurement of oral-cecal transit time in unanesthetized, freely moving mice via ...
10
DOI 10.1152/ajpendo.00397.2025
Open DOI
Validation in adult Black and White women of the ISS model for estimating insulin sensitivity and beta-cell function from mixed-meal tests
We have previously validated a differential equation model (the ISS model) to determine insulin sensitivity and beta-cell function from oral glucose tolerance tests. The ISS model is simpler to use and requires less data than other curre...
Bibliographical & Catalog Notes
Description based on: Vol. 41, no. 1 (Jan. 2000); title from cover.
Print issues ceased with v. 301, no. 6 (Dec. 2011)
Vols. for <2000-> also carry the numbering of the consolidated version of The American journal of physiology; i.e., v. <41-> also numbered as v. <278->.
Issued also on microfilm by UMI.
Also issued online.
Also issued as a section of the consolidated version of The American journal of physiology.
Continues in part: American journal of physiology. Endocrinology, metabolism and gastrointestinal physiology.